Breast Cancer Clinical Trial
Phase II Study of Intra-Operative Electron Irradiation and External Beam Irradiation After Lumpectomy in Patients With T1N0M0 and T2N0M0 Breast Cancer
Summary
The study is being done to determine the tolerance to single fraction intra-operative electron irradiation (IOERT) and external beam photon irradiation (EBRT) following lumpectomy for T1/T2N0M0 breast cancer. IOERT is used in lieu of the 5-8 days of electron beam boost irradiation that is usually given after EBRT. Data from two centers as well as preliminary data from a randomized trial in Europe suggest that IOERT boost is well tolerated and efficacious. In our study, patients will undergo standard lumpectomy and sentinel lymph node sampling or axillary dissection. After the lumpectomy, IOERT of 10 Gy will be delivered in a single fraction to the tumor bed by a mobile electron machine in the operating room. EBRT to the whole breast will be administered once the surgical wound has healed adequately. The primary objective is to determine the feasibility and acute patient tolerance to IOERT and EBRT after lumpectomy. Secondary objectives include assessment of local control and distant control of disease, as well as evaluation of long-term side effects and cosmetic outcome of the treatment.
Eligibility Criteria
Eligibility:
Histologically proven primary invasive breast carcinoma.
Tumor pathologically determined <= 5cm in diameter.
Single, discrete, well-defined primary tumor.
Any micro-calcifications must be focal. A specimen radiograph is required after lumpectomy to assure removal of all malignant appearing calcifications.
Pathologically negative surgical margins.
Axillary lymph node status can be determined by level I and II lymph node dissection or sentinel lymph node sampling.
ECOG performance status 0-2.
Contraindications:
Multicentric disease and/or diffuse malignant appearing microcalcifications.
Evidence of metastatic breast cancer.
Axillary lymph node involvement.
Pre-existing collagen vascular disease except rheumatoid arthritis that does not require immunosuppressive therapy.
Prior irradiation to the ara of planned radiation field.
Pregnant or lactating women.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Scottsdale Arizona, , United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.